Institutional Ownership
Newamsterdam Pharma Company
CUSIP N62509109ORDINARY SHARESQ1 2026
Institutional Holders
165
13F filers
Shares Held
122.74M
Aggregate institutional
Institutional Value
$3.81B
Q1 2026
Net New Holders
-16
19 new · 35 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions19
Increased68
Decreased49
Sold out35
Institutional Holders
165 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 16.94M | $542.37M | 0 | Held |
| 2 | Capital World Investors | 11.11M | $355.60M | +1.13M | Added |
| 3 | Ra Capital Management, L.P. | 9.55M | $305.70M | 0 | Held |
| 4 | Fcpm III Services B.V. | 9.20M | $294.46M | 0 | Held |
| 5 | Fmr LLC | 8.77M | $280.59M | +2.35M | Added |
| 6 | Bain Capital Life Sciences Investors, LLC | 7.31M | $233.88M | 0 | Held |
| 7 | Wellington Management Group LLP | 5.12M | $163.76M | +82.6K | Added |
| 8 | Deerfield Management Company, L.P. | 4.26M | $136.52M | +100.0K | Added |
| 9 | Viking Global Investors LP | 4.20M | $134.56M | 0 | Held |
| 10 | Polar Capital Holdings PLC | 2.83M | $90.64M | +55.4K | Added |
155 more institutional holders on Premium
See every fund holding Newamsterdam Pharma Company, with full quarter-over-quarter share changes.
Unlock all holders